12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·05/01/2026 12:05:59
Listen to the news
Gainers
- Cue Biopharma (NASDAQ:CUE) stock rose 90.1% to $28.02 during Friday's pre-market session. The company's market cap stands at $47.9 million.
- Esperion Therapeutics (NASDAQ:ESPR) stock increased by 57.0% to $3.14. The company's market cap stands at $514.8 million.
- Akanda (NASDAQ:AKAN) shares rose 30.26% to $63.78. The company's market cap stands at $26.1 million.
- Psyence Biomedical (NASDAQ:PBM) stock moved upwards by 19.11% to $7.85. The market value of their outstanding shares is at $6.7 million.
- iSpecimen (NASDAQ:ISPC) stock increased by 17.2% to $6.13. The company's market cap stands at $3.8 million.
- Cerus (NASDAQ:CERS) stock rose 15.02% to $2.33. The market value of their outstanding shares is at $406.7 million. As per the news, the Q1 earnings report came out yesterday.
Losers
- Akari Therapeutics (NASDAQ:AKTX) shares decreased by 25.9% to $4.0 during Friday's pre-market session. The market value of their outstanding shares is at $192.9 million.
- Senseonics Holdings (NASDAQ:SENS) shares fell 22.24% to $5.14. The company's market cap stands at $276.3 million.
- Rein Therapeutics (NASDAQ:RNTX) shares fell 21.78% to $1.06. The company's market cap stands at $37.9 million.
- Summit Therapeutics (NASDAQ:SMMT) stock decreased by 20.55% to $17.05. The company's market cap stands at $16.6 billion. As per the press release, Q1 earnings came out yesterday.
- Sotera Health (NASDAQ:SHC) stock decreased by 10.75% to $13.89. The market value of their outstanding shares is at $4.4 billion.
- Crescent Biopharma (NASDAQ:CBIO) stock decreased by 8.68% to $20.43. The company's market cap stands at $681.4 million. As per the press release, Q1 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.